advertisement
11.3.4 Betablocker (14)
Showing records 1 to 14
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker10124 Dorzolamide/timolol fixed combination versus concomitant administration of brimonidine and timolol in patients with elevated intraocular pressure: a 3-month comparison of efficacy, tolerability, and patient-reported measures
Solish AM; DeLucca PT; Cassel DA; Kolodny AH; Hustad CM; Skobieranda F
Journal of Glaucoma 2004; 13: 149-157
10133 Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma
Chew PT; Aung T; Aquino MV; Rojanapongpun P; EXACT Study Group
Ophthalmology 2004; 111: 427-434
10129 A 12-week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension
Diestelhorst M; Larsson LI; European Latanoprost Fixed Combination Study Group
British Journal of Ophthalmology 2004; 88: 199-203
10139 Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials
Fechtner RD; Airaksinen PJ; Getson AJ; Lines CR; Adamsons IA; COSOPT versus XALATAN Study Groups
Acta Ophthalmologica Scandinavica 2004; 82: 42-48
10468 An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension
Feldman RM
Expert Opinion in Pharmacotherapy 2004; 5: 909-921
10138 Optic nerve oxygen tension: the effects of timolol and dorzolamide
Kiilgaard JF; Pedersen DB; Eysteinsson T; la Cour M; Bang K; Jensen PK; Stefansson E
British Journal of Ophthalmology 2004; 88: 276-279
10136 Do selective topical beta antagonists for glaucoma have respiratory side effects?
Kirwan JF; Nightingale JA; Bunce C; Wormald R
British Journal of Ophthalmology 2004; 88: 196-198
10523 Binding affinity of bunazosin, dorzolamide, and timolol to synthetic melanin
Kiuchi Y; Terakawa N; Nakata T; Yamasaki K; Saito Y; Ito N; Okada K
Japanese Journal of Ophthalmology 2004; 48: 34-6
10131 Influence of peripheral iridectomy on intravitreous penetration of topical nipradilol
Mayama C; Tomidokoro A; Araie M; Mizuno K
Current Eye Research 2004; 28: 129-133
10493 Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma
Osborne NN; Wood JPM; Chidlow G; Casson R; DeSantis L; Schmidt KG
Brain Research Bulletin 2004; 62: 525-528
10132 Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure
Shin DH; Feldman RM; Sheu WP; Fixed Combination Latanoprost/Timolol Study Group
Ophthalmology 2004; 111: 276-282
10134 Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma
Sihota R; Saxena R; Agarwal HC; Gulati V
Archives of Ophthalmology 2004; 122: 185-189
10151 Safety comparison of topical brinzolamide 1% and timolol 0.5% in patients with asthma or chronic obstructive pulmonary disease
Friren B; Michaud JE; Mayolle C
Today's Therapeutic Trends 2004; 22: 69-80
10135 Long-term efficacy and safety of combined topical antiglaucoma therapy: timolol and unoprostone versus betaxolol and unoprostone
Ohtake Y; Tanino T; Kimura I; Mashima Y; Oguchi Y
Nippon Ganka Gakkai Zasshi 2004; 108: 23-28
